Dr. David Mazzo CEO Caladrius Biosciences Dr. Mazzo is the CEO of Caladrius Biosciences, a public cell therapy therapeutics development company. He is a pharmaceutical executive and strategic leader with >30 years of broad international experience. He is...
8th Annual Life Science Chief Executive Officer Forum: Speaker Interview Dr. David Mazzo CEO Caladrius Biosciences Dr. Mazzo is the CEO of Caladrius Biosciences, a public cell therapy therapeutics development company. He is a pharmaceutical executive and strategic...
This Week’s Top Headlines Merck to Begin Testing Alzheimer’s Treatment Theory Posted 2/15/17 Merck & Co. announced this week plans to begin testing a possible cause of Alzheimer’s. The testing is commencing after 200 patients were reviewed for three months...
Merck & Co. announced this week plans to begin testing a possible cause of Alzheimer’s. The testing is commencing after 200 patients were reviewed for three months while taking MK-8931, an experimental Merck drug which reduces a side effect of the illness. The...
In 2015, the medical device industry claimed that nearly 33,000 jobs had been lost since 2012 due to the Affordable Care Act’s device tax of 2.3%. Though former President Barak Obama signed a bill halting the tax for two years, the industry is fighting to have the tax...
